These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pretreatment plasminogen activator inhibitor-1 (PAI-1) levels and the outcome of thrombolysis with streptokinase in patients with acute myocardial infarction. Sinkovic A Am Heart J; 1998 Sep; 136(3):406-11. PubMed ID: 9736130 [TBL] [Abstract][Full Text] [Related]
4. The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction. El Menyar AA; Altamimi OM; Gomaa MM; Fawzy Z; Rahman MO; Bener A J Thromb Thrombolysis; 2006 Jun; 21(3):235-40. PubMed ID: 16683215 [TBL] [Abstract][Full Text] [Related]
5. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013 [TBL] [Abstract][Full Text] [Related]
6. Alterations in the fibrinolytic system components during acute myocardial infarction. Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123 [TBL] [Abstract][Full Text] [Related]
7. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Barbash GI; White HD; Modan M; Van de Werf F J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802 [TBL] [Abstract][Full Text] [Related]
8. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction. Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755 [TBL] [Abstract][Full Text] [Related]
9. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy]. Kobusiak-Prokopowicz M; Mysiak A Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704 [TBL] [Abstract][Full Text] [Related]
10. The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase. Nilsson JB; Boman K; Jansson JH; Nilsson T; Näslund U J Thromb Thrombolysis; 2008 Dec; 26(3):188-95. PubMed ID: 17721741 [TBL] [Abstract][Full Text] [Related]
11. Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction. Schwerdt H; Ozbek C; Fröhlig G; Schieffer H; Bette L Cardiovasc Res; 1990 Apr; 24(4):328-34. PubMed ID: 2189569 [TBL] [Abstract][Full Text] [Related]
12. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173 [TBL] [Abstract][Full Text] [Related]
13. Prognostic role of plasminogen-activator-inhibitor-1 levels in treatment with streptokinase of patients with acute myocardial infarction. Sinkovic A Clin Cardiol; 2000 Jul; 23(7):486-9. PubMed ID: 10894435 [TBL] [Abstract][Full Text] [Related]
14. Free-radical activity after reperfusion in diabetic and non-diabetic patients with acute myocardial infarction. Gray RP; Wickens DG; Patterson DL; Yudkin JS Clin Sci (Lond); 1993 Nov; 85(5):549-55. PubMed ID: 8287642 [TBL] [Abstract][Full Text] [Related]
15. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy. Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480 [TBL] [Abstract][Full Text] [Related]
16. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [TBL] [Abstract][Full Text] [Related]